BALA CYNWYD, Pa., Oct. 21, 2013 /PRNewswire/ -- Purolite announced today that it will develop bioseparation resins for chromatography based on agarose media that will be manufactured in their cGMP, FDA regulated facility. The new line will expand the LifeTech™ family of products to cover the SEC, HIC, IEX and affinity bio-purification media for the fast-growing biomolecules market.
The new products will launch in 2014 and support a range of customer needs from drug development with pre-packed columns to bulk media for industrial production of biomolecules. Standard and customized products will be available for the agarose product line. All Purolite products go through rigorous application testing.
"The Life science industry has been dominated for a long time by a few major producers as well as small niche companies," stated Dr. Alessandra Basso, Purolite LifeTech Manager. "With decades of critical application experience and a global, knowledgeable technical sales team dedicated to high-level service, Purolite is positioned to provide bioseparation resins that meet the most stringent demands for biotechnological research and applications."
Purolite Corporation is a leading manufacturer of ion exchange media, catalysts, adsorbents and advanced polymers. Headquartered in Bala Cynwyd, Pa., the company has ISO 9001 certified manufacturing facilities in the USA, China and Romania and operates dedicated R&D centers in the USA, China, Romania, Russia and the UK. Purolite, the only company focused exclusively on resin technology, has 40 sales offices in more than 30 countries.
Purolite Corporation is also one of the world's largest developers and manufacturers of high-quality APIs, blood purification polymers, enzyme carriers, and chromatographic resins for life sciences.
For further information on resins for bio-chromatography and the LifeTech family of products, visit www.purolite.com.
|SOURCE Purolite Corporation|
Copyright©2012 PR Newswire.
All rights reserved